Belluscura Past Earnings Performance

Past criteria checks 0/6

Belluscura's earnings have been declining at an average annual rate of -48.5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 45% per year.

Key information

-48.5%

Earnings growth rate

-30.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate45.0%
Return on equity-100.2%
Net Margin-1,030.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Belluscura makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9VQ Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242-19130
31 Mar 241-19130
31 Dec 231-19130
30 Sep 231-14110
30 Jun 231-1090
31 Mar 231-980
31 Dec 221-870
30 Sep 221-880
30 Jun 221-780
31 Mar 221-670
31 Dec 210-550
30 Sep 210-540
30 Jun 210-430
31 Mar 210-320
31 Dec 200-210
31 Dec 190-210
31 Dec 180-110
31 Dec 170-330
30 Nov 160-110

Quality Earnings: 9VQ is currently unprofitable.

Growing Profit Margin: 9VQ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9VQ is unprofitable, and losses have increased over the past 5 years at a rate of 48.5% per year.

Accelerating Growth: Unable to compare 9VQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9VQ is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 9VQ has a negative Return on Equity (-100.2%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 01:56
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Belluscura plc is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Paul RichardsDowgate Capital Stockbrokers Limited
David Joseph StormsStonegate Capital Markets, Inc.
David Joseph StormsStonegate Capital Partners, Inc.